ADCY9 and breast carcinoma: Some research found that ADCY9 acts as a key gene in the cisplatin response regulatory network in the pro-apoptotic stage in breast cancer treatment (Fallahi & Godini, 2019), and overexpression of ADCY9 is a poor prognostic marker for disease-free survival in colon cancer (Yi et al., 2018).